# OnCo record bezuclastinib (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/bezuclastinib/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "bezuclastinib" ;
  schema:name "Bezuclastinib"@en ;
  schema:description "Bezuclastinib is an experimental small-molecule drug from Cogent Biosciences in phase 3 trials for gastrointestinal stromal tumour, aimed at KIT and MET."@en ;
  schema:url <https://onco.cc/drugs/bezuclastinib/> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/search?intr=Bezuclastinib>, <https://www.cogentbio.com/pipeline> ;
  onco:status "phase-3" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "small molecule" ;
  onco:cancers <https://onco.cc/cancers/gist/>, <https://onco.cc/cancers/indolent-systemic-mastocytosis/>, <https://onco.cc/cancers/advanced-systemic-mastocytosis/> ;
  onco:targets <https://onco.cc/targets/kit/>, <https://onco.cc/targets/met/> ;
  onco:companies <https://onco.cc/companies/cogent-biosciences/> ;
  onco:trials <https://onco.cc/trials/nct05208047/>, <https://onco.cc/trials/nct05186753/>, <https://onco.cc/trials/nct04996875/> .